urea has been researched along with ascorbate-2-phosphate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busato, L; Fallacara, A; Ghadiri, M; Manfredini, S; Ong, HX; Pozzoli, M; Traini, D; Young, PM | 3 |
3 other study(ies) available for urea and ascorbate-2-phosphate
| Article | Year |
|---|---|
Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study.
Topics: Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Cross-Linking Reagents; Dose-Response Relationship, Drug; Drug Combinations; Drug Compounding; Electric Impedance; Epithelial Cells; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Interleukin-6; Lung; Lung Diseases, Obstructive; Osmolar Concentration; Reactive Oxygen Species; Technology, Pharmaceutical; Urea; Viscosity | 2018 |
In vitro characterization of physico-chemical properties, cytotoxicity, bioactivity of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Adult; Anti-Inflammatory Agents; Ascorbic Acid; Cell Line; Cell Survival; Epithelial Cells; Humans; Hyaluronic Acid; Interleukin-8; Lipopolysaccharides; Nasal Mucosa; Powders; Urea; Wound Healing; Young Adult | 2019 |
Co-Spray-Dried Urea Cross-Linked Hyaluronic Acid and Sodium Ascorbyl Phosphate as Novel Inhalable Dry Powder Formulation.
Topics: Administration, Inhalation; Aerosols; Anti-Inflammatory Agents; Ascorbic Acid; Cell Line, Tumor; Chemistry, Pharmaceutical; Cross-Linking Reagents; Desiccation; Drug Combinations; Drug Compounding; Drug Stability; Dry Powder Inhalers; Humans; Hyaluronic Acid; Lung Diseases; Particle Size; Powders; Urea | 2019 |